156 related articles for article (PubMed ID: 24580120)
1. The power of r - pharmaceutical sales decomposition in Cyprus public healthcare sector and determinants of drug expenditure evolution: any lessons learned?
Petrou P
Expert Rev Pharmacoecon Outcomes Res; 2014 Apr; 14(2):289-300. PubMed ID: 24580120
[TBL] [Abstract][Full Text] [Related]
2. International prices and availability of pharmaceuticals in 2005.
Danzon PM; Furukawa MF
Health Aff (Millwood); 2008; 27(1):221-33. PubMed ID: 18180499
[TBL] [Abstract][Full Text] [Related]
3. Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals.
Andersson K; Bergström G; Petzold MG; Carlsten A
Health Policy; 2007 May; 81(2-3):376-84. PubMed ID: 16945449
[TBL] [Abstract][Full Text] [Related]
4. Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved?
Cameron A; Mantel-Teeuwisse AK; Leufkens HG; Laing RO
Value Health; 2012; 15(5):664-73. PubMed ID: 22867775
[TBL] [Abstract][Full Text] [Related]
5. The impotence of price controls: failed attempts to constrain pharmaceutical expenditures in Greece.
Lambrelli D; O'Donnell O
Health Policy; 2011 Jul; 101(2):162-71. PubMed ID: 20884073
[TBL] [Abstract][Full Text] [Related]
6. Spending on medicines in Israel in an international context.
Sax P
Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
[TBL] [Abstract][Full Text] [Related]
7. The effect of generic competition on the price of brand-name drugs.
Lexchin J
Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
[TBL] [Abstract][Full Text] [Related]
8. Adoption of pharmaceutical innovation and the growth of drug expenditure in Taiwan: is it cost effective?
Hsieh CR; Sloan FA
Value Health; 2008; 11(2):334-44. PubMed ID: 18380646
[TBL] [Abstract][Full Text] [Related]
9. Public drug expenditure in the Republic of Ireland.
Barry M; Usher C; Tilson L
Expert Rev Pharmacoecon Outcomes Res; 2010 Jun; 10(3):239-45. PubMed ID: 20545588
[TBL] [Abstract][Full Text] [Related]
10. Price Determinants of the Tendering Process for Pharmaceuticals in the Cyprus Market.
Petrou P; Talias MA
Value Health Reg Issues; 2015 Sep; 7():67-73. PubMed ID: 29698154
[TBL] [Abstract][Full Text] [Related]
11. The impact of reference pricing of nonsteroidal anti-inflammatory agents on the use and costs of analgesic drugs.
Grootendorst PV; Marshall JK; Holbrook AM; Dolovich LR; O'Brien BJ; Levy AR
Health Serv Res; 2005 Oct; 40(5 Pt 1):1297-317. PubMed ID: 16174135
[TBL] [Abstract][Full Text] [Related]
12. The influences of Taiwan's generic grouping price policy on drug prices and expenditures: evidence from analysing the consumption of the three most-used classes of cardiovascular drugs.
Chen CL; Chen L; Yang WC
BMC Public Health; 2008 Apr; 8():118. PubMed ID: 18405385
[TBL] [Abstract][Full Text] [Related]
13. A pricing policy towards the sourcing of cheaper drugs in Cyprus.
Merkur S; Mossialos E
Health Policy; 2007 May; 81(2-3):368-75. PubMed ID: 16949176
[TBL] [Abstract][Full Text] [Related]
14. Influence of mandatory generic substitution on pharmaceutical sales patterns: a national study over five years.
Andersson KA; Petzold MG; Allebeck P; Carlsten A
BMC Health Serv Res; 2008 Feb; 8():50. PubMed ID: 18312635
[TBL] [Abstract][Full Text] [Related]
15. Generic drug utilisation on the General Medical Services (GMS) scheme in 2001.
Tilson L; McGowan B; Ryan M; Barry M
Ir Med J; 2003 Jun; 96(6):176-9. PubMed ID: 12926759
[TBL] [Abstract][Full Text] [Related]
16. Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform.
Wouters OJ; Kanavos PG
Bull World Health Organ; 2015 Sep; 93(9):606-13. PubMed ID: 26478624
[TBL] [Abstract][Full Text] [Related]
17. Drug Policy in Bulgaria.
Dimova A; Rohova M; Atanasova E; Kawalec P; Czok K
Value Health Reg Issues; 2017 Sep; 13():50-54. PubMed ID: 29073988
[TBL] [Abstract][Full Text] [Related]
18. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies.
Kersnik J; Peklar J
J Clin Pharm Ther; 2006 Dec; 31(6):577-83. PubMed ID: 17176362
[TBL] [Abstract][Full Text] [Related]
19. Generic drug prices and policy in Australia: room for improvement? a comparative analysis with England.
Mansfield SJ
Aust Health Rev; 2014 Feb; 38(1):6-15. PubMed ID: 24480618
[TBL] [Abstract][Full Text] [Related]
20. Effects of managerial intervention on drug utilization pattern at King Chulalongkorn Memorial Hospital.
Limpanasithikul W; Wangsaturaka D; Nantawan P; Itthipanichapong C; Thamaree S; Wittayalertpanya S; Ketcharoen A; Taworn N; Kemsri W; Kusolsomboon T; Tangphao O
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S336-43. PubMed ID: 12188432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
